Table 7.
Characteristic | Hazard Ratio | 95% CI | P Value |
Age (continuous) | 1.01 | 0.99-1.03 | .41 |
Sex: male vs female | 1.23 | 0.59-2.55 | .59 |
Days from initial therapy to bronchoscopy | 1.00 | 0.99-1.00 | .29 |
ECOG ≥ 2 | 2.21 | 1.09-4.47 | .03 |
Ever smoked | 1.61 | 0.72-3.59 | .25 |
COPD | 0.56 | 0.17-1.84 | .34 |
Congestive heart failure history | 0.79 | 0.11-5.81 | .82 |
Primary lung cancer vs metastatic disease | 1.75 | 0.87-3.53 | .12 |
Chemotherapy prior to bronchoscopy | 1.70 | 0.73-3.93 | .22 |
Chemotherapy after bronchoscopy | 0.21 | 0.10-0.45 | < .001 |
Radiation prior to bronchoscopy | 1.87 | 0.93-3.78 | .08 |
Radiation after bronchoscopy | 0.70 | 0.34-1.46 | .35 |
Stent placed initially | 2.87 | 1.40-5.89 | .004 |
Baseline airway obstruction > 50% | 1.94 | 0.89-4.20 | .09 |
Infection: yes vs no (time varying) | 11.07 | 3.84-31.96 | < .001 |
See Table 4 legend for expansion of abbreviations.